Global Topical Recombinant Human Thrombin Market Research Report 2024

Report ID: 1858279 | Published Date: Jan 2025 | No. of Page: 69 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Topical Recombinant Human Thrombin Market Overview
    1.1 Product Overview and Scope of Topical Recombinant Human Thrombin
    1.2 Topical Recombinant Human Thrombin Segment by Type
        1.2.1 Global Topical Recombinant Human Thrombin Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 2000/Bottle
        1.2.3 5000/Bottle
        1.2.4 Others
    1.3 Topical Recombinant Human Thrombin Segment by Application
        1.3.1 Global Topical Recombinant Human Thrombin Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Global Topical Recombinant Human Thrombin Market Size Estimates and Forecasts
        1.4.1 Global Topical Recombinant Human Thrombin Revenue 2017-2028
        1.4.2 Global Topical Recombinant Human Thrombin Sales 2017-2028
        1.4.3 Topical Recombinant Human Thrombin Market Size by Region: 2017 Versus 2021 Versus 2028
2 Topical Recombinant Human Thrombin Market Competition by Manufacturers
    2.1 Global Topical Recombinant Human Thrombin Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Topical Recombinant Human Thrombin Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Topical Recombinant Human Thrombin Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Topical Recombinant Human Thrombin Manufacturing Sites, Area Served, Product Type
    2.5 Topical Recombinant Human Thrombin Market Competitive Situation and Trends
        2.5.1 Topical Recombinant Human Thrombin Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Topical Recombinant Human Thrombin Players Market Share by Revenue
        2.5.3 Global Topical Recombinant Human Thrombin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Topical Recombinant Human Thrombin Retrospective Market Scenario by Region
    3.1 Global Topical Recombinant Human Thrombin Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Topical Recombinant Human Thrombin Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Topical Recombinant Human Thrombin Market Facts & Figures by Country
        3.3.1 North America Topical Recombinant Human Thrombin Sales by Country
        3.3.2 North America Topical Recombinant Human Thrombin Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Topical Recombinant Human Thrombin Market Facts & Figures by Country
        3.4.1 Europe Topical Recombinant Human Thrombin Sales by Country
        3.4.2 Europe Topical Recombinant Human Thrombin Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Topical Recombinant Human Thrombin Market Facts & Figures by Region
        3.5.1 Asia Pacific Topical Recombinant Human Thrombin Sales by Region
        3.5.2 Asia Pacific Topical Recombinant Human Thrombin Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Topical Recombinant Human Thrombin Market Facts & Figures by Country
        3.6.1 Latin America Topical Recombinant Human Thrombin Sales by Country
        3.6.2 Latin America Topical Recombinant Human Thrombin Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Topical Recombinant Human Thrombin Market Facts & Figures by Country
        3.7.1 Middle East and Africa Topical Recombinant Human Thrombin Sales by Country
        3.7.2 Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Topical Recombinant Human Thrombin Historic Market Analysis by Type
    4.1 Global Topical Recombinant Human Thrombin Sales Market Share by Type (2017-2022)
    4.2 Global Topical Recombinant Human Thrombin Revenue Market Share by Type (2017-2022)
    4.3 Global Topical Recombinant Human Thrombin Price by Type (2017-2022)
5 Global Topical Recombinant Human Thrombin Historic Market Analysis by Application
    5.1 Global Topical Recombinant Human Thrombin Sales Market Share by Application (2017-2022)
    5.2 Global Topical Recombinant Human Thrombin Revenue Market Share by Application (2017-2022)
    5.3 Global Topical Recombinant Human Thrombin Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Baxter
        6.1.1 Baxter Corporation Information
        6.1.2 Baxter Description and Business Overview
        6.1.3 Baxter Topical Recombinant Human Thrombin Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Baxter Topical Recombinant Human Thrombin Product Portfolio
        6.1.5 Baxter Recent Developments/Updates
    6.2 Suzhou Zelgen Biopharmaceuticals
        6.2.1 Suzhou Zelgen Biopharmaceuticals Corporation Information
        6.2.2 Suzhou Zelgen Biopharmaceuticals Description and Business Overview
        6.2.3 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product Portfolio
        6.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
    6.3 Pfizer
        6.3.1 Pfizer Corporation Information
        6.3.2 Pfizer Description and Business Overview
        6.3.3 Pfizer Topical Recombinant Human Thrombin Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Pfizer Topical Recombinant Human Thrombin Product Portfolio
        6.3.5 Pfizer Recent Developments/Updates
7 Topical Recombinant Human Thrombin Manufacturing Cost Analysis
    7.1 Topical Recombinant Human Thrombin Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Topical Recombinant Human Thrombin
    7.4 Topical Recombinant Human Thrombin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Topical Recombinant Human Thrombin Distributors List
    8.3 Topical Recombinant Human Thrombin Customers
9 Topical Recombinant Human Thrombin Market Dynamics
    9.1 Topical Recombinant Human Thrombin Industry Trends
    9.2 Topical Recombinant Human Thrombin Market Drivers
    9.3 Topical Recombinant Human Thrombin Market Challenges
    9.4 Topical Recombinant Human Thrombin Market Restraints
10 Global Market Forecast
    10.1 Topical Recombinant Human Thrombin Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Topical Recombinant Human Thrombin by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Topical Recombinant Human Thrombin by Type (2023-2028)
    10.2 Topical Recombinant Human Thrombin Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Topical Recombinant Human Thrombin by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Topical Recombinant Human Thrombin by Application (2023-2028)
    10.3 Topical Recombinant Human Thrombin Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Topical Recombinant Human Thrombin by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Topical Recombinant Human Thrombin by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Topical Recombinant Human Thrombin Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Topical Recombinant Human Thrombin Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Topical Recombinant Human Thrombin Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Topical Recombinant Human Thrombin Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Topical Recombinant Human Thrombin Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Topical Recombinant Human Thrombin Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Topical Recombinant Human Thrombin Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Topical Recombinant Human Thrombin Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Topical Recombinant Human Thrombin Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Topical Recombinant Human Thrombin Manufacturing Sites and Area Served
    Table 11. Manufacturers Topical Recombinant Human Thrombin Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Topical Recombinant Human Thrombin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Topical Recombinant Human Thrombin as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Topical Recombinant Human Thrombin Sales by Region (2017-2022) & (K Units)
    Table 16. Global Topical Recombinant Human Thrombin Sales Market Share by Region (2017-2022)
    Table 17. Global Topical Recombinant Human Thrombin Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Topical Recombinant Human Thrombin Revenue Market Share by Region (2017-2022)
    Table 19. North America Topical Recombinant Human Thrombin Sales by Country (2017-2022) & (K Units)
    Table 20. North America Topical Recombinant Human Thrombin Sales Market Share by Country (2017-2022)
    Table 21. North America Topical Recombinant Human Thrombin Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Topical Recombinant Human Thrombin Revenue Market Share by Country (2017-2022)
    Table 23. Europe Topical Recombinant Human Thrombin Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Topical Recombinant Human Thrombin Sales Market Share by Country (2017-2022)
    Table 25. Europe Topical Recombinant Human Thrombin Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Topical Recombinant Human Thrombin Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Topical Recombinant Human Thrombin Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Topical Recombinant Human Thrombin Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Topical Recombinant Human Thrombin Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Topical Recombinant Human Thrombin Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Topical Recombinant Human Thrombin Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Topical Recombinant Human Thrombin Sales Market Share by Country (2017-2022)
    Table 33. Latin America Topical Recombinant Human Thrombin Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Topical Recombinant Human Thrombin Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Topical Recombinant Human Thrombin Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Topical Recombinant Human Thrombin Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Topical Recombinant Human Thrombin Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Topical Recombinant Human Thrombin Revenue Market Share by Country (2017-2022)
    Table 39. Global Topical Recombinant Human Thrombin Sales by Type (2017-2022) & (K Units)
    Table 40. Global Topical Recombinant Human Thrombin Sales Market Share by Type (2017-2022)
    Table 41. Global Topical Recombinant Human Thrombin Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Topical Recombinant Human Thrombin Revenue Share by Type (2017-2022)
    Table 43. Global Topical Recombinant Human Thrombin Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Topical Recombinant Human Thrombin Sales (K Units) by Application (2017-2022)
    Table 45. Global Topical Recombinant Human Thrombin Sales Market Share by Application (2017-2022)
    Table 46. Global Topical Recombinant Human Thrombin Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Topical Recombinant Human Thrombin Revenue Share by Application (2017-2022)
    Table 48. Global Topical Recombinant Human Thrombin Price by Application (2017-2022) & (US$/Unit)
    Table 49. Baxter Corporation Information
    Table 50. Baxter Description and Business Overview
    Table 51. Baxter Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Baxter Topical Recombinant Human Thrombin Product
    Table 53. Baxter Recent Developments/Updates
    Table 54. Suzhou Zelgen Biopharmaceuticals Corporation Information
    Table 55. Suzhou Zelgen Biopharmaceuticals Description and Business Overview
    Table 56. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product
    Table 58. Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
    Table 59. Pfizer Corporation Information
    Table 60. Pfizer Description and Business Overview
    Table 61. Pfizer Topical Recombinant Human Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Pfizer Topical Recombinant Human Thrombin Product
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Production Base and Market Concentration Rate of Raw Material
    Table 65. Key Suppliers of Raw Materials
    Table 66. Topical Recombinant Human Thrombin Distributors List
    Table 67. Topical Recombinant Human Thrombin Customers List
    Table 68. Topical Recombinant Human Thrombin Market Trends
    Table 69. Topical Recombinant Human Thrombin Market Drivers
    Table 70. Topical Recombinant Human Thrombin Market Challenges
    Table 71. Topical Recombinant Human Thrombin Market Restraints
    Table 72. Global Topical Recombinant Human Thrombin Sales Forecast by Type (2023-2028) & (K Units)
    Table 73. Global Topical Recombinant Human Thrombin Sales Market Share Forecast by Type (2023-2028)
    Table 74. Global Topical Recombinant Human Thrombin Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 75. Global Topical Recombinant Human Thrombin Revenue Market Share Forecast by Type (2023-2028)
    Table 76. Global Topical Recombinant Human Thrombin Sales Forecast by Application (2023-2028) & (K Units)
    Table 77. Global Topical Recombinant Human Thrombin Sales Market Share Forecast by Application (2023-2028)
    Table 78. Global Topical Recombinant Human Thrombin Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 79. Global Topical Recombinant Human Thrombin Revenue Market Share Forecast by Application (2023-2028)
    Table 80. Global Topical Recombinant Human Thrombin Sales Forecast by Region (2023-2028) & (K Units)
    Table 81. Global Topical Recombinant Human Thrombin Sales Market Share Forecast by Region (2023-2028)
    Table 82. Global Topical Recombinant Human Thrombin Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 83. Global Topical Recombinant Human Thrombin Revenue Market Share Forecast by Region (2023-2028)
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Topical Recombinant Human Thrombin
    Figure 2. Global Topical Recombinant Human Thrombin Market Share by Type in 2021 & 2028
    Figure 3. 2000/Bottle Product Picture
    Figure 4. 5000/Bottle Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Topical Recombinant Human Thrombin Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Clinic
    Figure 9. Global Topical Recombinant Human Thrombin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Topical Recombinant Human Thrombin Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Topical Recombinant Human Thrombin Sales (2017-2028) & (K Units)
    Figure 12. Topical Recombinant Human Thrombin Sales Share by Manufacturers in 2021
    Figure 13. Global Topical Recombinant Human Thrombin Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Topical Recombinant Human Thrombin Players: Market Share by Revenue in 2021
    Figure 15. Topical Recombinant Human Thrombin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Topical Recombinant Human Thrombin Sales Market Share by Region (2017-2022)
    Figure 17. Global Topical Recombinant Human Thrombin Sales Market Share by Region in 2021
    Figure 18. Global Topical Recombinant Human Thrombin Revenue Market Share by Region (2017-2022)
    Figure 19. Global Topical Recombinant Human Thrombin Revenue Market Share by Region in 2021
    Figure 20. United States Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Topical Recombinant Human Thrombin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Topical Recombinant Human Thrombin by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Topical Recombinant Human Thrombin
    Figure 44. Manufacturing Process Analysis of Topical Recombinant Human Thrombin
    Figure 45. Topical Recombinant Human Thrombin Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Baxter
Suzhou Zelgen Biopharmaceuticals
Pfizer
Frequently Asked Questions
Topical Recombinant Human Thrombin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Topical Recombinant Human Thrombin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Topical Recombinant Human Thrombin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Measuring Stirrers

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More